Inventor · disambiguated record
Ana Kostic
Also filed as: KOSTIC ANA
9 granted patents·5 pending applications·142 citations·filing 2011–2023
87Inventor score
Top patents by PatentIndex Score
14 records- 0195US9228014B2Antibodies capable of blocking the interaction between CD48 and a CD48 receptorCLASSON BRENDAN J·Filed 2011·Granted Jan 5, 2016·78 cites·21 claims
- 0294US9290574B2Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitorREGENERON PHARMA·Filed 2014·Granted Mar 22, 2016·32 cites·46 claims
- 0393US10730948B2Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitorREGENERON PHARMA·Filed 2016·Granted Aug 4, 2020·16 cites·20 claims
- 0491US11421036B2Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)REGENERON PHARMA·Filed 2020·Granted Aug 23, 2022·2 cites·16 claims
- 0586US9790273B2Anti-HLA-B*27 antibodies and uses thereofREGENERON PHARMA·Filed 2013·Granted Oct 17, 2017·10 cites·15 claims
- 0684US11352417B2Method of treating an allergy with allergen-specific monoclonal antibodiesREGENERON PHARMA·Filed 2017·Granted Jun 7, 2022·2 cites·9 claims
- 0782US11325980B2Combination therapy using a LIV1-ADC and a chemotherapeuticSEATTLE GENETICS INC·Filed 2017·Granted May 10, 2022·2 cites·12 claims
- 0879US12291571B2Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibodyREGENERON PHARMA·Filed 2022·Granted May 6, 2025·0 cites·27 claims
- 0969US2023203141A1Methods of treating an allergy with allergen-specific monoclonal antibodiesREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1068US2023235083A1Combination therapy using a liv1-adc and a chemotherapeuticSEAGEN INC·Filed 2022·Application pending·0 cites
- 1167US2024076402A1Humanized anti-liv1 antibodies for the treatment of breast cancerSEAGEN INC·Filed 2023·Application pending·0 cites
- 1256US2020283540A1Humanized anti-liv1 antibodies for the treatment of breast cancerSEATTLE GENETICS INC·Filed 2018·Application pending·0 cites
- 1347US9533039B2Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodiesREGENERON PHARMA·Filed 2013·Granted Jan 3, 2017·0 cites·14 claims
- 1445US2020230254A1Combination therapy using a cd19-adc and rchpSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ana Kostic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →